Clinical Trials Sponsored by Acerus Pharmaceutical

Total 20004 results

Acutus Medical

Completed

Dipole Density Mapping in Supraventricular Tachycardia (DDRAMATIC-SVT)

Supraventricular Tachycardia

United Kingdom, Canada, Czechia, Belgium, Chile, Germany
Acutus Medical

Withdrawn

Dipole Density Mapping of Right and Left Atrial Supraventricular Tachycardia (DDRAMATIC-SVT)

Supraventricular Tachycardia

Ireland
Aleris Helse

Completed

Perioperative Hypothermia Hypothermia in Ambulatory Surgery

Perioperative/Postoperative Complications

Norway
Agenus Inc.

Terminated

Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma

United States
Agenus Inc.

Completed

Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer

Renal Cell Carcinoma

United States, France, Poland, United Kingdom, Spain, Israel, Canada, Belgium, Norway, Sweden, Austria
Agenus Inc.

Completed

Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma

Malignant Melanoma

United States, Australia, Poland, Ukraine, United Kingdom, Russian Federation, Hungary, Italy, Sweden
Agenus Inc.

Active, not recruiting

Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer

Advanced Cancer

United States
Agenus Inc.

Suspended

A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma

Advanced Melanoma

United States, Spain, United Kingdom, France, Germany, Switzerland, Belgium, Italy, Brazil, Russian Federation
Acutus Medical

Completed

AcQBlate Force Sensing Ablation System US IDE for Atrial Flutter (AcQForce Flutter) (AcQForce AFL)

Typical Atrial Flutter

Belgium, United States, United Kingdom
Agenus Inc.

Completed

Subjects With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors (Cervical)

Cervical Cancer

United States, Hungary, Spain, Australia, Ukraine, Georgia, Poland, Brazil, Moldova, Republic of
Acutus Medical

Completed

AcQBlate Force Sensing Ablation System EU Study for Atrial Flutter (AcQForce Flutter-EU) (AFL-EU)

Typical Atrial Flutter

Belgium, United Kingdom
Acutus Medical

Withdrawn

Pulmonary Vein Isolation Plus Left Atrial Slow Zone Mapping and Ablation (PLASZMA)

Atrial Arrhythmias
Acutus Medical

Withdrawn

AcQBlate Force Confirmatory Study for Atrial Arrhythmias

Atrial Arrhythmias

Czechia
Agenus Inc.

Terminated

Study of AGEN1884 With Pembrolizumab in 1L NSCLC

NSCLC Stage IV

New Zealand, Australia
Agenus Inc.

Terminated

Safety and Tolerability Study of AutoSynVax™ Vaccine in Subjects With Advanced Cancer

Advanced Cancer

United States
Aleris Obesity

Completed

Effects of Long Biliopancreatic Limb vs. Long Alimentary Limb in Superobesity, a Randomized Study

Weight Loss | Morbid Obesity

Sweden
Acutus Medical

Completed

Dipole Density Mapping of Typical Atrial Flutter (DDRAMATIC)

Atrial Flutter

Germany
Agenus Inc.

Terminated

Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer

Kidney Cancer | Renal Cell Carcinoma

United States, Canada
Agenus Inc.

Completed

Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer

Lung Cancer | Non-Small-Cell Lung Carcinoma | Pulmonary Cancer

United Kingdom
Agenus Inc.

Completed

Trial Evaluating Safety, Tolerability and Immune Response of AG-707

Genital Herpes

United States
Aeras

Completed

Biological Samples Obtained by Leukapheresis Induced by Two BCG Vaccinations in BCG-naïve Healthy Adults in the US ((A-051))

Tuberculosis

United States
Aeras

Completed

A Study to Evaluate Safety and Immunogenicity of AERAS-402 Administered in HIV-negative, BCG-vaccinated, QFT (+) and (-) Adults Without Evidence of TB (C-012-402)

Tuberculosis

Kenya
Acerta Pharma BV
Acerta Pharma, LLC

Completed

An Open-Label, Phase 1b Study of Acalabrutinib With and Without Dexamethasone in Subjects With Multiple Myeloma

Multiple Myeloma (MM)

United States, United Kingdom
Swiss Transfusion SRC
Cerus Corporation

Withdrawn

INTERCEPT Safety Evaluation on Whole Blood (POINT1africa)

Safety Issues
Aleris Eye

Recruiting

Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods

Cataract

Sweden
Agenus Inc.

Active, not recruiting

A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer

Metastatic Colorectal Cancer

United States, France, Belgium, Spain, Italy, Brazil, Russian Federation, Georgia
Agenus Inc.

Active, not recruiting

Study of AGEN1571 in Participants With Advanced Solid Tumors

Advanced Solid Tumor

United States
Agenus Inc.

Available

Expanded Access for Cancer Treatment With Balstilimab (AGEN2034) and Zalifrelimab (AGEN1884)

Cancer
Acutus Medical

Completed

AcQMap 2.1 With Electro-Magnetic Tracking System Feasibility Study (EMT Feasibility Study)

Catheter Ablation

United States
Acutus Medical

Terminated

AcQMap® US Registry of Procedural and Long-term Clinical Outcomes (Discover-US)

Ablation of Arrhythmia's

United States
Acutus Medical

Completed

AcQForce Pulsed Field Ablation-CE (PFA-AF)

Atrial Fibrillation | Atrial Arrhythmia

Czechia
Agenus Inc.

Completed

A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma

Lymphoma, Follicular | Lymphoma, Small Lymphocytic

United States
Aleris Hospital

Active, not recruiting

Non-randomized Prospective Comparison Between SASI Bipartition and RYGB

Postoperative Complications | Metabolic Syndrome | Obesity, Morbid | Bariatric Surgery Candidate

Norway
Agenus Inc.

Terminated

A Study in Subjects With Advanced Solid Tumors

Advanced Solid Tumor

United States
Agenus Inc.

Completed

Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital Herpes

Herpes Simplex Type 2

United States
Agenus Inc.

Terminated

Study of Vitespen (HSPPC-96, Oncophage ®) for Immune Response Assessment in Participants With Resectable Renal Cell Carcinoma at Intermediate Risk of Recurrence

Renal Cell Carcinoma

United States, Canada
Acutus Medical

Completed

Dipole Density Right Atrial Mapping and Assessment of Therapy In Cavotricuspid Isthmus Flutter (DDRAMATIC)

Atrial Flutter

Belgium
Agenus Inc.

Terminated

AG-858 in Patients Who Are Cytogenetically Positive After Treatment With Gleevec™

Leukemia, Myeloid, Chronic

United States, United Kingdom
Agenus Inc.

Completed

Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma

B-Cell Lymphoma | Malignancies

United States
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment

Postmenopausal Women With Advanced Breast Cancer

Japan
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Aeras

Completed

A Leukapheresis Study for Immune Responses in Healthy US Adults Who Receive BCG Vaccination Followed by Boosting With AERAS-402 (C-021-402)

Tuberculosis
Aeras

Completed

A Study to Evaluate Safety and Immunogenicity of AERAS-402

Tuberculosis

India
Aeras

Completed

Study of AERAS 422 in Healthy Adults

Tuberculosis

United States
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Acerta Pharma BV

Active, not recruiting

Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Participants With High Risk Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

United States, Italy, Spain, United Kingdom, Belgium, Denmark, Hungary, Poland, Australia, Germany, Israel, Netherlands, Turkey, France, New Zealand
Acerta Pharma BV

Active, not recruiting

A Study of AZD6738 and Acalabrutinib in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

United Kingdom, Poland
Acerta Pharma BV

Completed

A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, Food Effects, and Drug-drug Interactions of ACP-196 in Healthy Participants

Healthy Participants

United States
Acerta Pharma BV

Terminated

A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies

DLBCL | Richter Syndrome

United Kingdom, United States
Acerta Pharma BV

Completed

ACP-196 Versus Placebo in Subjects With Rheumatoid Arthritis on Background Methotrexate

Rheumatoid Arthritis

United States

3

Subscribe